SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEMASURE (HMSR) - Buyout in the works?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: who wrote ()2/25/1997 10:36:00 PM
From: hcm1943   of 88
 
This thread went dead and I can't understand why. HMSR,

while a stellar underperformer can be a shooting star if


a couple of things happen.

1) they somehow someway eliminate the problem created

when they bot the plasma business from Norvo Nordisk

(from what I hear that may be very soon)

2) the filter business takes off (i've heard they

shipped more filters in Jan than in the entire 4th qtr)

3)steripath becomes a success (it's early but it's a

cheap bet. if it works could be a BILLION DOLLAR mkt)



`
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News